TXG - 10x Genomics, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
Pleasanton,
United States
Type: Equity
TXG price evolution
TXG
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $359.28 | $314.74 | $330.85 | $339.79 |
| Short term investments | $29.41 | $45.64 | $65.51 | $85.97 |
| Net receivables | $114.83 | $103.85 | $87.69 | $77.94 |
| Inventory | $73.71 | $80.92 | $83.69 | $82.31 |
| Total current assets | $596.02 | $562.35 | $582.94 | $601.89 |
| Long term investments | ||||
| Property, plant & equipment | $344.93 | $354.2 | $355.96 | $366.84 |
| Goodwill & intangible assets | $21.13 | $26.34 | $26.8 | $27.46 |
| Total noncurrent assets | $369.12 | $386.19 | $406.7 | $412.14 |
| Total investments | $29.41 | $45.64 | $65.51 | $85.97 |
| Total assets | $965.14 | $948.54 | $989.64 | $1014.03 |
| Current liabilities | ||||
| Accounts payable | $15.74 | $18.84 | $23.12 | $29.32 |
| Deferred revenue | $21.96 | $11.14 | $9.22 | $8.53 |
| Short long term debt | $11.52 | $10.01 | $9.29 | $9.2 |
| Total current liabilities | $127.16 | $104.72 | $98.09 | $112.01 |
| Long term debt | $83.85 | $88.47 | $90.33 | $92.84 |
| Total noncurrent liabilities | $96.94 | $98.61 | $98.25 | $99.64 |
| Total debt | $95.37 | $98.47 | $99.62 | $102.04 |
| Total liabilities | $224.1 | $203.32 | $196.34 | $211.65 |
| Shareholders' equity | ||||
| Retained earnings | -$1284.42 | -$1235.47 | -$1142.48 | -$1080.07 |
| Other shareholder equity | -$0.43 | -$0.68 | -$0.97 | -$1.48 |
| Total shareholder equity | $741.04 | $745.22 | $793.3 | $802.38 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $359.28 | $227.35 | $596.07 | $688.64 |
| Short term investments | $29.41 | $210.24 | ||
| Net receivables | $114.83 | $104.21 | $85.25 | $51.21 |
| Inventory | $73.71 | $81.63 | $59.97 | $29.96 |
| Total current assets | $596.02 | $635.03 | $747.59 | $774.37 |
| Long term investments | ||||
| Property, plant & equipment | $344.93 | $359.21 | $230.41 | $119.82 |
| Goodwill & intangible assets | $21.13 | $27.37 | $29.91 | |
| Total noncurrent assets | $369.12 | $393.94 | $271.24 | $154.97 |
| Total investments | $29.41 | $210.24 | ||
| Total assets | $965.14 | $1028.98 | $1018.83 | $929.34 |
| Current liabilities | ||||
| Accounts payable | $15.74 | $21.6 | $17.35 | $4.71 |
| Deferred revenue | $21.96 | $7.87 | $5.34 | $4.47 |
| Short long term debt | $11.52 | $9.04 | $5.13 | $5.94 |
| Total current liabilities | $127.16 | $130.96 | $110.36 | $118.13 |
| Long term debt | $83.85 | $86.14 | $76.85 | $57.04 |
| Total noncurrent liabilities | $96.94 | $92.28 | $90.9 | $72.14 |
| Total debt | $95.37 | $95.18 | $81.98 | $62.98 |
| Total liabilities | $224.1 | $223.24 | $201.26 | $190.27 |
| Shareholders' equity | ||||
| Retained earnings | -$1284.42 | -$1029.32 | -$863.32 | -$805.1 |
| Other shareholder equity | -$0.43 | -$4.33 | $0.02 | -$0.05 |
| Total shareholder equity | $741.04 | $805.74 | $817.57 | $739.07 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $183.98 | $153.64 | $146.82 | $134.28 |
| Cost of revenue | $68.2 | $58.12 | $47.21 | $35.9 |
| Gross Profit | $115.78 | $95.53 | $99.61 | $98.39 |
| Operating activities | ||||
| Research & development | $65.27 | $66.51 | $71.46 | $67.1 |
| Selling, general & administrative | $86.13 | $82.42 | $91.51 | $83.28 |
| Total operating expenses | $170.97 | $190.32 | $162.97 | $150.38 |
| Operating income | -$55.19 | -$94.8 | -$63.36 | -$51.99 |
| Income from continuing operations | ||||
| EBIT | -$46.59 | -$91.74 | -$60.76 | -$49.63 |
| Income tax expense | $2.35 | $1.24 | $1.65 | $1.09 |
| Interest expense | $0.01 | $0 | $0.01 | $0.02 |
| Net income | ||||
| Net income | -$48.95 | -$92.99 | -$62.41 | -$50.75 |
| Income (for common shares) | -$48.95 | -$92.99 | -$62.41 | -$50.75 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $618.73 | $516.41 | $490.49 | $298.85 |
| Cost of revenue | $209.41 | $120.39 | $74.09 | $58.47 |
| Gross Profit | $409.31 | $396.02 | $416.4 | $240.38 |
| Operating activities | ||||
| Research & development | $270.33 | $265.67 | $211.75 | $123.38 |
| Selling, general & administrative | $343.33 | $298.3 | $257.56 | $202.33 |
| Total operating expenses | $674.64 | $563.97 | $468.65 | $774.52 |
| Operating income | -$265.33 | -$167.94 | -$52.25 | -$534.14 |
| Income from continuing operations | ||||
| EBIT | -$248.73 | -$161.5 | -$52.85 | -$532.79 |
| Income tax expense | $6.34 | $4.03 | $4.51 | $8.26 |
| Interest expense | $0.03 | $0.48 | $0.87 | $1.68 |
| Net income | ||||
| Net income | -$255.1 | -$166 | -$58.22 | -$542.73 |
| Income (for common shares) | -$255.1 | -$166 | -$58.22 | -$542.73 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$48.95 | -$92.99 | -$62.41 | -$50.75 |
| Operating activities | ||||
| Depreciation | $11.71 | $11.42 | $11.88 | $8.62 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $38.92 | $40.23 | $45.7 | $42.1 |
| Total cash flows from operations | $25.76 | -$25.3 | -$11.53 | -$4.13 |
| Investing activities | ||||
| Capital expenditures | -$3.45 | -$15.24 | -$25.36 | -$4.56 |
| Investments | $16.55 | $20.34 | $20.89 | $125.24 |
| Total cash flows from investing | $13.1 | $4.9 | -$4.46 | $119.96 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $5.61 | $4.37 | $7.1 | $2.4 |
| Net borrowings | $5.81 | -$5.81 | ||
| Total cash flows from financing | $5.61 | $4.37 | $7.1 | -$3.41 |
| Effect of exchange rate | $0.08 | -$0.09 | -$0.05 | $0.02 |
| Change in cash and equivalents | $44.55 | -$16.11 | -$8.94 | $112.44 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$255.1 | -$166 | -$58.22 | -$542.73 |
| Operating activities | ||||
| Depreciation | $43.62 | $33.01 | $28.25 | $19.02 |
| Business acquisitions & disposals | -$4 | -$5.45 | ||
| Stock-based compensation | $166.95 | $136.85 | $95.96 | $48.63 |
| Total cash flows from operations | -$15.2 | -$33.61 | -$21.37 | -$217.9 |
| Investing activities | ||||
| Capital expenditures | -$48.6 | -$131.66 | -$101.28 | -$36.67 |
| Investments | $183.02 | -$215.23 | ||
| Total cash flows from investing | $133.49 | -$350.89 | -$106.73 | -$38.39 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $19.48 | $21.23 | $40.33 | $506.01 |
| Net borrowings | -$37.1 | |||
| Total cash flows from financing | $13.67 | $15.82 | $35.3 | $468.91 |
| Effect of exchange rate | -$0.03 | -$0.04 | $0.23 | -$0.46 |
| Change in cash and equivalents | $131.93 | -$368.72 | -$92.57 | $212.15 |
News
Fundamentals
| Market cap | $3.45B |
|---|---|
| Enterprise value | $3.18B |
| Shares outstanding | 119.10M |
| Revenue | $618.73M |
|---|---|
| EBITDA | -$205.11M |
| EBIT | -$248.73M |
| Net Income | -$255.10M |
| Revenue Q/Q | 17.76% |
| Revenue Y/Y | 19.81% |
| P/E ratio | -13.52 |
|---|---|
| EV/Sales | 5.15 |
| EV/EBITDA | -15.52 |
| EV/EBIT | -12.80 |
| P/S ratio | 5.57 |
| P/B ratio | 4.65 |
| Book/Share | 6.23 |
| Cash/Share | 3.02 |
| EPS | -$2.14 |
|---|---|
| ROA | -26.05% |
| ROE | -33.11% |
| Debt/Equity | 0.30 |
|---|---|
| Net debt/EBITDA | 0.66 |
| Current ratio | 4.69 |
| Quick ratio | 4.11 |